1. Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer
   Braydon Meyer et al, 2021, Clinical Epigenetics CrossRef
2. Maternal Copy Number Imbalances in Non-Invasive Prenatal Testing: Do They Matter?
   Michaela Hyblova et al, 2022, Diagnostics CrossRef
3. MicroRNA‑197‑3p acts as a prognostic marker and inhibits cell invasion in hepatocellular carcinoma
   Jun‑Sheng Ni et al, 2018, Oncology Letters CrossRef
4. Epigenetic Regulation of miR-92a and TET2 and Their Association in Non-Hodgkin Lymphoma
   Esther K. Elliott et al, 2021, Frontiers in Genetics CrossRef
5. m6A methyltransferase METTL14‑mediated RP1‑228H13.5 promotes the occurrence of liver cancer by targeting hsa‑miR‑205/ZIK1
   Jia Xu et al, 2024, Oncology Reports CrossRef
6. Genome-wide DNA methylation analysis using MethylCap-seq in canine high-grade B-cell lymphoma
   Chia-Hsin Hsu et al, 2021, Journal of Leukocyte Biology CrossRef
7. Analysis of methylation‐driven genes for predicting the prognosis of patients with head and neck squamous cell carcinoma
   Yihua Pan et al, 2019, Journal of Cellular Biochemistry CrossRef
8. Genomic profiling for clinical decision making in lymphoid neoplasms
   Laurence de Leval et al, 2022, Blood CrossRef
9. LTBP2 inhibits prostate cancer progression and metastasis via the PI3K/AKT signaling pathway
   Xiaowen Zhang et al, 2022, Experimental and Therapeutic Medicine CrossRef
10. Targeting DNA Methylation in Leukemia, Myelodysplastic Syndrome, and Lymphoma: A Potential Diagnostic, Prognostic, and Therapeutic Tool
    Lenka Kalinkova et al, 2022, International Journal of Molecular Sciences CrossRef
11. Revealing molecular and cellular heterogeneity in hypopharyngeal carcinogenesis through single-cell RNA and TCR/BCR sequencing
    Cheng-Wei Tie et al, 2024, Frontiers in Immunology CrossRef